GCTKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Glucotrack, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026
- Market cap
- $3.43M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Glucotrack statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Glucotrack | Industry median |
|---|---|---|
| Market Cap | $7.24M | $230.55M |
| Enterprise Value | $6.12M | $202.97M |
Income (trailing twelve months)
| Measure | Glucotrack | Industry median |
|---|---|---|
| Operating Income | -$15.40M | -$4.31M |
| Net Income | -$15.95M | -$6.57M |
| EBITDA | -$15.40M | -$1.98M |
Returns
| Measure | Glucotrack | Industry median |
|---|---|---|
| Return on Equity (ROE) | -620.6% | -18.2% |
| Return on Assets (ROA) | -272.5% | -13.3% |
Growth
| Measure | Glucotrack | Industry median |
|---|---|---|
| EPS Growth (3Y CAGR) | -28.9% | 3.11% |
| EPS Growth (5Y CAGR) | -11.3% | 7.64% |
Balance sheet
| Measure | Glucotrack | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.12M | $36.66M |
| Net Cash (Debt) | $1.12M | $3.92M |
| Net Cash Per Share | $0.11 | $0.28 |
| Equity (Book Value) | -$1.74M | $55.33M |
| Book Value Per Share | -$0.16 | $2.87 |
| Tangible Book Value | -$1.74M | $10.79M |
| Working Capital | -$1.61M | $56.72M |
Financial position
| Measure | Glucotrack | Industry median |
|---|---|---|
| Current Ratio | 0.46 | 2.48 |
| Quick Ratio | 0.38 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Glucotrack | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.22M | -$566.22K |
Efficiency
| Measure | Glucotrack | Industry median |
|---|---|---|
| Profits Per Employee | -$1.06M | -$51.88K |
| Employee Count | 15 | 185 |
Dividends and yields
| Measure | Glucotrack | Industry median |
|---|---|---|
| Earnings Yield | -220.2% | -6.88% |
Shares
| Measure | Glucotrack | Industry median |
|---|---|---|
| Shares Outstanding | 10,578,800 | 44,302,700 |
| Shares Change (YoY) | 1149.3% | 3.36% |
| Shares Change (QoQ) | 148.0% | 0.27% |
| Float | 7,815,900 | 37,462,700 |
| Shares Held by Insiders | 26.1% | 10.5% |
Scores
| Measure | Glucotrack | Industry median |
|---|---|---|
| Altman Z-Score | -183.76 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Glucotrack's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.